Roshantha A.S. Chandraratna

Biochemistry, Genetics and Molecular Biology · Life Sciences

54h-index9.3kcitations190works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Retinoids in leukemia and cellular processes(138), Estrogen and related hormone effects(75), Antioxidant Activity and Oxidative Stress(36), interferon and immune responses(16), Immune Cell Function and Interaction(14)

Publications190 total

Supplementary Figure Legends 1-2 from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 2 from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 1 from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Data from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Data from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 1 from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure Legends 1-2 from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Supplementary Figure 2 from A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8<sup>+</sup> T Cells
2023Open Access
Repurposing a novel anti-cancer RXR agonist to attenuate murine acute GVHD and maintain graft-versus-leukemia responses
Blood·2020· 10 citedOpen Access
Synthesis and Studies of 12-S-CIS Conformationally Locked Retinoids
2018· 1 cited
Critical Roles of Retinoic Acid Signaling in Combating Acute Graft Versus Host Disease
Blood·2016
Selective brain penetrable Nurr1 transactivator for treating Parkinson's disease
Oncotarget·2016· 47 citedOpen Access
Treatment with retinoid X receptor agonist IRX4204 ameliorates experimental autoimmune encephalomyelitis.
PubMed·2016· 37 citedOpen Access
RAR-Alpha Targeting Compounds Overcome Bone Marrow (BM) Stromal Protection of AML By CYP26
Blood·2015· 1 cited
RARγ is a negative regulator of osteoclastogenesis
The Journal of Steroid Biochemistry and Molecular Biology·2015· 28 cited
Active repression by RARγ signaling is required for vertebrate axial elongation
Development·2014· 41 citedOpen Access
Inhibiting retinoic acid signaling ameliorates graft-versus-host disease by modifying T-cell differentiation and intestinal migration
Blood·2013· 51 citedOpen Access
Rexinoids as modulators of central nervous system inflammation (P5125)
The Journal of Immunology·2013
Erratum: Corrigendum: Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor–γ agonists
Nature Medicine·2012· 2 citedOpen Access
A Retinoic Acid—Rich Tumor Microenvironment Provides Clonal Survival Cues for Tumor-Specific CD8+ T Cells
Cancer Research·2012· 53 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Sunil Nagpal(10), Madeleine Duvic(6), Corine Ghosn(4), Richard A. Heyman(4), Peter J. Davies(4), Richard L. Eckert(4), A. T. Charlie Johnson(4), Scott M. Thacher(4), Maurizio Pacifici(3), Sheetal Patel(3), Daniel DiSepio(3), Min Teng(3), Bruce Blumberg(3), Arisa Asano(3), Richard L. Beard(3), Ellen A. Rorke(3), Kengo Shimono(2), Wei-en Tung(2), Masahiro Iwamoto(2), Monica Malhotra(2)